Detalles de la búsqueda
1.
The metabolite profiling of YR-1702 injection in human plasma, urine and feces by HPLC-Q-TOF-MS/MS.
Xenobiotica
; 53(8-9): 536-546, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37850428
2.
LC-MS/MS methods for determination of unstable pivmecillinam and mecillinam in acidified human plasma: Application to a pharmacokinetic study.
J Sep Sci
; 45(14): 2543-2554, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35593582
3.
Method development and validation for simultaneous determination of ebastine and its active metabolite carebastine in human plasma by liquid chromatography-tandem mass spectrometry and its application to a clinical pharmacokinetic study in healthy Chinese volunteers.
Biomed Chromatogr
; 34(10): e4904, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32449558
4.
Development and validation of LC-MS/MS methods for the quantification of 101BHG-D01, a novel, long-acting and selective muscarinic receptor antagonist, and its main metabolite M6 in human plasma, urine and feces: Application to a clinical study in healthy Chinese subjects.
J Pharm Biomed Anal
; 233: 115498, 2023 Sep 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37285657
5.
Pharmacokinetics, metabolite profiling, safety and tolerability of YZJ-4729 tartrate, a novel G protein-biased µ-opioid receptor agonist, in healthy Chinese subjects.
Front Pharmacol
; 14: 1295319, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38264529
6.
Pharmacokinetics, Mass Balance, Tissue Distribution and Metabolism of [14C]101BHG-D01, a Novel Muscarinic Receptor Antagonist, in Rats.
Curr Drug Metab
; 24(11): 770-779, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38073103
7.
Pharmacokinetics, metabolite profiling, safety, and tolerability of inhalation aerosol of 101BHG-D01, a novel, long-acting and selective muscarinic receptor antagonist, in healthy Chinese subjects.
Front Pharmacol
; 13: 1064364, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36588683
Resultados
1 -
7
de 7
1
Próxima >
>>